Dissecting the EGFR-PI3K-AKT pathway in oral cancer highlights the role of the EGFR variant III and its clinical relevance-Reference-Cited by-同舟云学术

Dissecting the EGFR-PI3K-AKT pathway in oral cancer highlights the role of the EGFR variant III and its clinical relevance

Published:2013 Issue:1 Volume:20 Page:43
ISSN:1423-0127
Container-title:Journal of Biomedical Science
language:en
Short-container-title:J Biomed Sci

Author:

Chang Kwang-Yu,Tsai Shan-Yin,Chen Shang-Hung,Tsou Hsiao-Hui,Yen Chia-Jui,Liu Ko-Jiunn,Fang Hsun-Lang,Wu Hung-Chang,Chuang Bin-Fay,Chou Shao-Wen,Tang Careen K,Liu Shyun-Yeu,Lu Pei-Jung,Yen Ching-Yu,Chang Jang-Yang

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Biochemistry, medical,Cell Biology,Clinical Biochemistry,Molecular Biology,General Medicine,Endocrinology, Diabetes and Metabolism

Reference42 articles.

1. Global cancer statistics

2. Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan

3. The Induction of Prostaglandin E2 Production, Interleukin-6 Production, Cell Cycle Arrest, and Cytotoxicity in Primary Oral Keratinocytes and KB Cancer Cells by Areca Nut Ingredients Is Differentially Regulated by MEK/ERK Activation

4. The precancer risk of betel quid chewing, tobacco use and alcohol consumption in oral leukoplakia and oral submucous fibrosis in southern Taiwan

5. EGFR Antagonists in Cancer Treatment

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural β-carotene based nanodrug: A promising phosphatidylinositol 3-kinase targeting strategy to treat oral carcinogenesis;Chemical Engineering Journal;2024-10

2. Overcoming Resistance to Standard-of-Care Therapies for Head and Neck Squamous Cell Carcinomas;Cells;2024-06-11

3. The anti-hepatocellular carcinoma effect of Aidi injection was related to the synergistic action of cantharidin, formononetin, and isofraxidin through BIRC5, FEN1, and EGFR;Journal of Ethnopharmacology;2024-01

4. Tolypothrix Dichloromethane Ethylacetate fraction (TDEF) inhibits cisplatin resistance H357 cell through PI3K/AKT/beta-catenin pathway;American Journal of Cancer Research;2024

5. Integrating machine learning and high throughput screening for the discovery of allosteric AKT1 inhibitors;Journal of Biomolecular Structure and Dynamics;2023-12-14